Logo image of ITI

Iteris Incorporated New (ITI) Stock Fundamental Analysis

NASDAQ:ITI - Nasdaq - US46564T1079 - Common Stock - Currency: USD

7.19  -0.01 (-0.14%)

Premarket: 7.19 0 (0%)

Fundamental Rating

5

Taking everything into account, ITI scores 5 out of 10 in our fundamental rating. ITI was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. ITI has an average financial health and profitability rating. While showing a medium growth rate, ITI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ITI had positive earnings in the past year.
ITI had a positive operating cash flow in the past year.
In multiple years ITI reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ITI reported negative operating cash flow in multiple years.
ITI Yearly Net Income VS EBIT VS OCF VS FCFITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.12%, ITI is in line with its industry, outperforming 54.84% of the companies in the same industry.
ITI's Return On Equity of 1.99% is in line compared to the rest of the industry. ITI outperforms 55.65% of its industry peers.
With a Return On Invested Capital value of 1.26%, ITI perfoms like the industry average, outperforming 53.23% of the companies in the same industry.
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROIC 1.26%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ITI Yearly ROA, ROE, ROICITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ITI has a Profit Margin (0.80%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ITI has declined.
Looking at the Operating Margin, with a value of 0.64%, ITI is in line with its industry, outperforming 51.61% of the companies in the same industry.
In the last couple of years the Operating Margin of ITI has grown nicely.
ITI's Gross Margin of 37.38% is fine compared to the rest of the industry. ITI outperforms 63.71% of its industry peers.
In the last couple of years the Gross Margin of ITI has remained more or less at the same level.
Industry RankSector Rank
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
ITI Yearly Profit, Operating, Gross MarginsITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ITI is destroying value.
ITI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ITI has more shares outstanding
There is no outstanding debt for ITI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ITI Yearly Shares OutstandingITI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ITI Yearly Total Debt VS Total AssetsITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ITI has an Altman-Z score of 3.69. This indicates that ITI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.69, ITI is doing good in the industry, outperforming 62.10% of the companies in the same industry.
There is no outstanding debt for ITI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.69
ROIC/WACC0.13
WACC9.39%
ITI Yearly LT Debt VS Equity VS FCFITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ITI has a Current Ratio of 1.77. This is a normal value and indicates that ITI is financially healthy and should not expect problems in meeting its short term obligations.
ITI has a Current ratio of 1.77. This is in the lower half of the industry: ITI underperforms 70.16% of its industry peers.
A Quick Ratio of 1.44 indicates that ITI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.44, ITI is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.44
ITI Yearly Current Assets VS Current LiabilitesITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

ITI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.67%, which is quite impressive.
Measured over the past years, ITI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -34.58% on average per year.
The Revenue has been growing slightly by 4.99% in the past year.
Measured over the past years, ITI shows a quite strong growth in Revenue. The Revenue has been growing by 13.01% on average per year.
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%

3.2 Future

Based on estimates for the next years, ITI will show a very strong growth in Earnings Per Share. The EPS will grow by 101.85% on average per year.
ITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.26% yearly.
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ITI Yearly Revenue VS EstimatesITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ITI Yearly EPS VS EstimatesITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 239.67 indicates a quite expensive valuation of ITI.
ITI's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.33, ITI is valued quite expensively.
ITI is valuated rather expensively with a Price/Forward Earnings ratio of 21.57.
Based on the Price/Forward Earnings ratio, ITI is valued a bit cheaper than 70.16% of the companies in the same industry.
ITI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
ITI Price Earnings VS Forward Price EarningsITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

ITI's Enterprise Value to EBITDA ratio is in line with the industry average.
ITI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 235.51
EV/EBITDA 55.92
ITI Per share dataITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

ITI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ITI's earnings are expected to grow with 101.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y118.21%
EPS Next 3Y101.85%

0

5. Dividend

5.1 Amount

No dividends for ITI!.
Industry RankSector Rank
Dividend Yield N/A

Iteris Incorporated New

NASDAQ:ITI (10/31/2024, 8:13:36 PM)

Premarket: 7.19 0 (0%)

7.19

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners69.2%
Inst Owner Change-2.13%
Ins Owners3.66%
Ins Owner Change-51.25%
Market Cap309.46M
Analysts46.67
Price Target7.34 (2.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.39%
Min EPS beat(2)-100%
Max EPS beat(2)-78.79%
EPS beat(4)1
Avg EPS beat(4)-47.55%
Min EPS beat(4)-100%
Max EPS beat(4)32.01%
EPS beat(8)3
Avg EPS beat(8)4.7%
EPS beat(12)3
Avg EPS beat(12)-309.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)2.58%
Revenue beat(4)2
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)3.89%
Revenue beat(8)6
Avg Revenue beat(8)4.6%
Revenue beat(12)6
Avg Revenue beat(12)2.15%
Revenue beat(16)8
Avg Revenue beat(16)1.61%
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)12.49%
EPS NQ rev (3m)-47.06%
EPS NY rev (1m)1.88%
EPS NY rev (3m)-38.64%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
P/S 1.78
P/FCF 235.51
P/OCF 83.41
P/B 4.4
P/tB 9.33
EV/EBITDA 55.92
EPS(TTM)0.03
EY0.42%
EPS(NY)0.33
Fwd EY4.64%
FCF(TTM)0.03
FCFY0.42%
OCF(TTM)0.09
OCFY1.2%
SpS4.05
BVpS1.63
TBVpS0.77
PEG (NY)1.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROCE 1.39%
ROIC 1.26%
ROICexc 1.71%
ROICexgc 4.57%
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
FCFM 0.75%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y41.57%
ROICexcg growth 5YN/A
ROICexc growth 3Y34.52%
ROICexc growth 5YN/A
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
F-Score8
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 59.44%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 72.01%
Profit Quality 94.06%
Current Ratio 1.77
Quick Ratio 1.44
Altman-Z 3.69
F-Score8
WACC9.39%
ROIC/WACC0.13
Cap/Depr(3y)59.96%
Cap/Depr(5y)55.27%
Cap/Sales(3y)1.51%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A
EBIT growth 1Y114.75%
EBIT growth 3Y26.28%
EBIT growth 5YN/A
EBIT Next Year275.63%
EBIT Next 3Y96.04%
EBIT Next 5YN/A
FCF growth 1Y108.39%
FCF growth 3Y17.68%
FCF growth 5YN/A
OCF growth 1Y126.16%
OCF growth 3Y20.58%
OCF growth 5YN/A